About this FactMed analysis covering adverse side effect reports of GLUCAGON patients who developed THERAPY NON-RESPONDER.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking GLUCAGON reported THERAPY NON-RESPONDER to the FDA. A total of 494 GLUCAGON drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between GLUCAGON and THERAPY NON-RESPONDER. In doing so, we compare GLUCAGON with other drugs that cause THERAPY NON-RESPONDER, to help you evaluate whether or not GLUCAGON causes THERAPY NON-RESPONDER. Likewise, this page shows the most highly-reported side effects of GLUCAGON, so you can see if THERAPY NON-RESPONDER ranks among GLUCAGON's most well-known side effects.
Summary Statistics
Reports of GLUCAGON causing THERAPY NON-RESPONDER: 1
Reports of any side effect of GLUCAGON : 494
Percentage of GLUCAGON patients where THERAPY NON-RESPONDER is a reported side effect: 0.2024%

FDA reports of any drug causing THERAPY NON-RESPONDER : 3953
Average percentage for all medicated patients where THERAPY NON-RESPONDER is reported as a complication: 0.0248%

Physician opinion on GLUCAGON as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing GLUCAGON:
PRODUCT USED FOR UNKNOWN INDICATION ( 44 patients )
HYPOGLYCAEMIA ( 33 patients )
DRUG USE FOR UNKNOWN INDICATION ( 20 patients )
DIABETES MELLITUS ( 11 patients )
TYPE 2 DIABETES MELLITUS ( 10 patients )
BLOOD GLUCOSE DECREASED ( 9 patients )
GASTROINTESTINAL ENDOSCOPIC THERAPY ( 8 patients )
DIAGNOSTIC PROCEDURE ( 8 patients )
INTESTINAL POLYPECTOMY ( 7 patients )
HYPERGLYCAEMIA ( 6 patients )
GLUCAGON TOLERANCE TEST ( 5 patients )
COLONOSCOPY ( 4 patients )
ENDOSCOPY UPPER GASTROINTESTINAL TRACT ( 4 patients )
ENDOSCOPY ( 3 patients )
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ( 3 patients )
ENDOSCOPY GASTROINTESTINAL ( 3 patients )
GASTRIC CANCER ( 2 patients )
HYPOGLYCAEMIA NEONATAL ( 2 patients )
HYPOGLYCAEMIC UNCONSCIOUSNESS ( 2 patients )
HEPATITIS FULMINANT ( 2 patients )
CONVULSION ( 2 patients )
DIABETES MELLITUS INSULIN-DEPENDENT ( 2 patients )
OESOPHAGEAL FOOD IMPACTION ( 1 patients )
RESUSCITATION ( 1 patients )
BLOOD GLUCOSE INCREASED ( 1 patients )
DIABETIC COMA ( 1 patients )
LOSS OF CONSCIOUSNESS ( 1 patients )
GASTROINTESTINAL DISORDER ( 1 patients )
SHOCK HYPOGLYCAEMIC ( 1 patients )
GASTROINTESTINAL OBSTRUCTION ( 1 patients )
CARDIOGENIC SHOCK ( 1 patients )
X-RAY ( 1 patients )
HYPOGLYCAEMIC SEIZURE ( 1 patients )
HYPOTENSION ( 1 patients )
JAUNDICE ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with THERAPY NON-RESPONDER:

ASPIRIN (270 patients)
VIOXX (237 patients)
REMICADE (177 patients)
METHOTREXATE (173 patients)
ACCUTANE (150 patients)
PREDNISONE (148 patients)
LIPITOR (146 patients)
PREDNISOLONE (128 patients)
CYCLOPHOSPHAMIDE (126 patients)
FUROSEMIDE (122 patients)
LASIX (113 patients)
NEURONTIN (101 patients)
ATENOLOL (101 patients)
ACETAMINOPHEN (96 patients)
PEGASYS (95 patients)
CELEBREX (91 patients)
NORVASC (90 patients)
LISINOPRIL (89 patients)
AVONEX (86 patients)
OMEPRAZOLE (86 patients)
FOLIC ACID (85 patients)
CYCLOSPORINE (80 patients)
COPEGUS (78 patients)
SYNTHROID (78 patients)
DEXAMETHASONE (77 patients)
ALBUTEROL (71 patients)
ALLOPURINOL (70 patients)
IBUPROFEN (64 patients)
OXYCONTIN (64 patients)
PREDNISONE TAB (63 patients)
LEVOTHYROXINE SODIUM (63 patients)
CYTARABINE (61 patients)
LEXAPRO (59 patients)
PROTONIX (58 patients)
DIGOXIN (58 patients)
PLAVIX (57 patients)
LANSOPRAZOLE (57 patients)
SOLU-MEDROL (56 patients)
METHYLPREDNISOLONE (56 patients)
ARANESP (56 patients)
HYDROCHLOROTHIAZIDE (55 patients)
ZOLOFT (55 patients)
VELCADE (54 patients)
CANCIDAS (54 patients)
PROGRAF (54 patients)
MORPHINE (54 patients)
XANAX (53 patients)
PREVACID (52 patients)
PAXIL (52 patients)
VINCRISTINE (51 patients)
DECADRON (50 patients)
VANCOMYCIN (50 patients)
COUMADIN (50 patients)
PRILOSEC (49 patients)
BEXTRA (49 patients)
ATORVASTATIN CALCIUM (48 patients)
PROZAC (48 patients)
LORAZEPAM (48 patients)
ZOCOR (47 patients)
SIMVASTATIN (47 patients)
ACYCLOVIR (47 patients)
VICODIN (47 patients)
NEXIUM (46 patients)
ZYPREXA (45 patients)
WARFARIN SODIUM (45 patients)
FLUOROURACIL (44 patients)
ATIVAN (44 patients)
GEMZAR (43 patients)
TOPROL-XL (43 patients)
RIBAVIRIN (43 patients)
CLONAZEPAM (42 patients)
TEGRETOL (42 patients)
AMBIEN (41 patients)
PEG-INTRON (41 patients)
LAMIVUDINE (40 patients)
EFFEXOR (40 patients)
VIAGRA (40 patients)
FLUCONAZOLE (39 patients)
GLEEVEC (39 patients)
FORTEO (39 patients)
FENTANYL (39 patients)
PREMARIN (38 patients)
DOXORUBICIN HCL (38 patients)
NITROGLYCERIN (37 patients)
TRAZODONE HCL (37 patients)
HEPARIN (37 patients)
INSULIN (36 patients)
FOSAMAX (36 patients)
LEVAQUIN (36 patients)
AZATHIOPRINE (36 patients)
OXYCODONE HCL (36 patients)
PROPOFOL (36 patients)
RANITIDINE (35 patients)
CLOFARABINE (34 patients)
REBETOL (34 patients)
HUMALOG (34 patients)
AVASTIN (33 patients)
ALPRAZOLAM (33 patients)
CISPLATIN (33 patients)
ENALAPRIL MALEATE (33 patients)
ALL OTHER THERAPEUTIC PRODUCTS (ALL OTHER THERAPEUTIC PRODUCTS) (33 patients)
DIAZEPAM (33 patients)
NEUPOGEN (33 patients)
AMITRIPTYLINE HCL (33 patients)
WELLBUTRIN (32 patients)
ETOPOSIDE (32 patients)
BENADRYL (32 patients)
HYDROCORTISONE (32 patients)
DURAGESIC-100 (31 patients)
SPIRONOLACTONE (31 patients)
ZANTAC (31 patients)
ATROVENT (31 patients)
VALIUM (31 patients)
CARBOPLATIN (31 patients)
CIPROFLOXACIN (31 patients)
PERCOCET (31 patients)
METOPROLOL (31 patients)
AMLODIPINE (30 patients)
SEROQUEL (30 patients)
ZYRTEC (30 patients)
TRAMADOL HCL (30 patients)
FLONASE (30 patients)
CELLCEPT (30 patients)
VERAPAMIL (30 patients)
FAMOTIDINE (30 patients)
MORPHINE SULFATE (30 patients)
THALOMID (29 patients)
ACTOS (29 patients)
NIFEDIPINE (29 patients)
ZOFRAN (28 patients)
BACTRIM (28 patients)
GABAPENTIN (28 patients)
GLYBURIDE (28 patients)
LITHIUM CARBONATE (28 patients)
ENBREL (28 patients)
MULTI-VITAMINS (27 patients)
MYCOPHENOLATE MOFETIL (27 patients)
TAXOTERE (27 patients)
ACETYLSALICYLIC ACID SRT (27 patients)
INTRON A (27 patients)
TYLENOL (27 patients)
DIFLUCAN (27 patients)
FLUOXETINE (27 patients)
BACLOFEN (27 patients)
ADVAIR DISKUS 100/50 (27 patients)
MIRTAZAPINE (27 patients)
AMOXICILLIN (26 patients)
METOPROLOL TARTRATE (26 patients)
DILTIAZEM (26 patients)
MULTI-VITAMIN (26 patients)
CLONIDINE (26 patients)
METOCLOPRAMIDE (26 patients)
MAGNESIUM OXIDE (26 patients)
KEPPRA (25 patients)
AMARYL (25 patients)
IRESSA (25 patients)
GLUCOPHAGE (25 patients)
VOLTAREN (25 patients)
CLARITIN (25 patients)
RISPERDAL (25 patients)
CLOPIDOGREL (25 patients)
AMPHOTERICIN B (25 patients)
SINGULAIR (25 patients)
CARBAMAZEPINE (25 patients)
POTASSIUM CHLORIDE (25 patients)
ALDACTONE (25 patients)
LYRICA (25 patients)
PLACEBO (24 patients)
PANTOPRAZOLE SODIUM (24 patients)
DIOVAN (24 patients)
CAPTOPRIL (23 patients)
DETROL LA (23 patients)
ZOMETA (23 patients)
PROCRIT (23 patients)
METFORMIN HCL (23 patients)
CELEXA (23 patients)
LEVOFLOXACIN (23 patients)
BOTOX (23 patients)
RAPAMUNE (22 patients)
BETASERON (22 patients)
ITRACONAZOLE (22 patients)
AZITHROMYCIN (22 patients)
TYLENOL (CAPLET) (22 patients)
VITAMIN E (22 patients)
INDOCIN I.V. (21 patients)
K-DUR 10 (21 patients)
DEXAMETHASONE TAB (21 patients)
DIDANOSINE (21 patients)
ZIDOVUDINE (21 patients)
LAMICTAL (21 patients)
ZITHROMAX (21 patients)
STAVUDINE (21 patients)
LORTAB (21 patients)
VORICONAZOLE (21 patients)
CLARITHROMYCIN (21 patients)
CALCIUM GLUCONATE (21 patients)
TOPAMAX (21 patients)
LANTUS (21 patients)
ISOSORBIDE MONONITRATE (21 patients)
VIREAD (21 patients)
VFEND (20 patients)
LOVENOX (20 patients)
ZETIA (20 patients)
METRONIDAZOLE (20 patients)
ZOLPIDEM TARTRATE (20 patients)
FLOVENT (20 patients)
DAUNORUBICIN HCL (20 patients)
SEREVENT (20 patients)
PREDONINE (20 patients)
CIPRO (20 patients)
Most common side effects for patients taking GLUCAGON:
HYPOTENSION (59 patients)
DYSPNOEA (58 patients)
NAUSEA (58 patients)
VOMITING (53 patients)
PNEUMONIA (49 patients)
ASTHENIA (45 patients)
BLOOD GLUCOSE INCREASED (44 patients)
RENAL FAILURE (44 patients)
DIZZINESS (43 patients)
PAIN (42 patients)
DEHYDRATION (40 patients)
HYPOAESTHESIA (39 patients)
HYPOGLYCAEMIA (39 patients)
ANAEMIA (38 patients)
RENAL FAILURE ACUTE (38 patients)
FATIGUE (37 patients)
BLOOD GLUCOSE DECREASED (37 patients)
ANXIETY (36 patients)
LOSS OF CONSCIOUSNESS (31 patients)
ABDOMINAL PAIN (30 patients)
CHEST PAIN (29 patients)
PAIN IN EXTREMITY (28 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (28 patients)
DIARRHOEA (28 patients)
ATRIAL FIBRILLATION (27 patients)
CARDIAC FAILURE CONGESTIVE (27 patients)
HYPOXIA (26 patients)
DEEP VEIN THROMBOSIS (26 patients)
URINARY TRACT INFECTION (26 patients)
SEPSIS (25 patients)
PULMONARY OEDEMA (24 patients)
CONVULSION (23 patients)
RESPIRATORY FAILURE (23 patients)
MENTAL STATUS CHANGES (21 patients)
DIABETES MELLITUS (21 patients)
HYPERTENSION (21 patients)
BACK PAIN (20 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
PLEURAL EFFUSION (20 patients)
DRUG INEFFECTIVE (20 patients)
CELLULITIS (20 patients)
ARRHYTHMIA (19 patients)
THROMBOCYTOPENIA (19 patients)
COUGH (19 patients)
BRADYCARDIA (19 patients)
OEDEMA PERIPHERAL (19 patients)
CARDIOGENIC SHOCK (19 patients)
NEUROPATHY PERIPHERAL (19 patients)
SPINAL COLUMN STENOSIS (19 patients)
FALL (18 patients)
INJURY (18 patients)
ARTHRALGIA (18 patients)
CONFUSIONAL STATE (18 patients)
BONE DISORDER (18 patients)
HYPERHIDROSIS (18 patients)
CHOLELITHIASIS (18 patients)
HYPOMAGNESAEMIA (18 patients)
PARAESTHESIA (17 patients)
HAEMORRHOIDS (17 patients)
INFECTION (17 patients)
MYOCARDIAL INFARCTION (17 patients)
PULMONARY EMBOLISM (17 patients)
ASTHMA (17 patients)
HEPATIC FAILURE (17 patients)
WEIGHT DECREASED (17 patients)
GASTROINTESTINAL HAEMORRHAGE (17 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (17 patients)
MALAISE (16 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (16 patients)
PYREXIA (16 patients)
SWELLING (16 patients)
DYSPHAGIA (16 patients)
BLOOD PRESSURE DECREASED (16 patients)
OSTEONECROSIS OF JAW (16 patients)
VENTRICULAR TACHYCARDIA (15 patients)
HEADACHE (15 patients)
ELECTROLYTE IMBALANCE (15 patients)
LOOSE TOOTH (15 patients)
AZOTAEMIA (15 patients)
OBESITY (15 patients)
SEPTIC SHOCK (15 patients)
HYPERKALAEMIA (15 patients)
PAIN IN JAW (14 patients)
SCOLIOSIS (14 patients)
TOOTH EXTRACTION (14 patients)
LIVER DISORDER (14 patients)
TRANSFUSION (14 patients)
RESPIRATORY DISTRESS (14 patients)
GAIT DISTURBANCE (14 patients)
TOOTH LOSS (14 patients)
TREMOR (14 patients)
DECREASED APPETITE (14 patients)
DECREASED INTEREST (14 patients)
HYPERGLYCAEMIA (14 patients)
MULTI-ORGAN FAILURE (14 patients)
CONSTIPATION (13 patients)
RENAL MASS (13 patients)
MUSCULOSKELETAL PAIN (13 patients)
ANAEMIA OF CHRONIC DISEASE (13 patients)
SCIATICA (13 patients)
DENTAL CARIES (13 patients)
HYPONATRAEMIA (13 patients)
ECONOMIC PROBLEM (13 patients)
ARTHROPATHY (13 patients)
ORAL INFECTION (13 patients)
INTERMITTENT CLAUDICATION (13 patients)
HAEMOLYSIS (13 patients)
INSOMNIA (13 patients)
INTERVERTEBRAL DISC PROTRUSION (13 patients)
PULMONARY HYPERTENSION (13 patients)
RENAL CYST (13 patients)
OSTEOLYSIS (13 patients)
SENSORY LOSS (13 patients)
GASTRITIS (13 patients)
CATARACT (13 patients)
ROTATOR CUFF SYNDROME (13 patients)
HIATUS HERNIA (13 patients)
SPINAL OSTEOARTHRITIS (13 patients)
PLATELET COUNT DECREASED (13 patients)
OSTEOMYELITIS (12 patients)
COMA (12 patients)
CARDIAC ARREST (12 patients)
VISION BLURRED (12 patients)
MEDICATION ERROR (12 patients)
SLEEP DISORDER (12 patients)
GINGIVAL BLEEDING (12 patients)
HAEMANGIOMA (12 patients)
ANHEDONIA (11 patients)
TENDONITIS (11 patients)
ATELECTASIS (11 patients)
METABOLIC ACIDOSIS (11 patients)
SPEECH DISORDER (11 patients)
PUBIS FRACTURE (11 patients)
HEART RATE INCREASED (11 patients)
EXOSTOSIS (11 patients)
BURSITIS (11 patients)
OSTEONECROSIS (11 patients)
CARDIOMEGALY (11 patients)
JAW DISORDER (10 patients)
DEATH (10 patients)
DIVERTICULITIS (10 patients)
PATHOLOGICAL FRACTURE (10 patients)
DYSGEUSIA (10 patients)
INTERVERTEBRAL DISC DEGENERATION (10 patients)
DEPRESSION (10 patients)
SOFT TISSUE DISORDER (10 patients)
HAEMATOMA (10 patients)
ENCEPHALOPATHY (10 patients)
HAEMATEMESIS (10 patients)
SKIN ULCER (10 patients)
CEREBROVASCULAR ACCIDENT (10 patients)
ABDOMINAL DISTENSION (9 patients)
ENDOTRACHEAL INTUBATION (9 patients)
INCORRECT DOSE ADMINISTERED (9 patients)
EXPOSED BONE IN JAW (9 patients)
TENDERNESS (9 patients)
CORONARY ARTERY DISEASE (9 patients)
HYPOGLYCAEMIC UNCONSCIOUSNESS (9 patients)
SYNCOPE (9 patients)
NECK PAIN (9 patients)
HAEMODIALYSIS (9 patients)
GINGIVITIS (9 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (9 patients)
HYPOGLYCAEMIC COMA (9 patients)
BONE LESION (9 patients)
RENAL FAILURE CHRONIC (9 patients)
TOOTHACHE (9 patients)
BREAKTHROUGH PAIN (9 patients)
OVERDOSE (9 patients)
CARDIAC OUTPUT DECREASED (9 patients)
FISTULA (9 patients)
CARDIO-RESPIRATORY ARREST (9 patients)
CEREBELLAR ISCHAEMIA (9 patients)
SWELLING FACE (9 patients)
MULTIPLE INJURIES (9 patients)
STAPHYLOCOCCAL BACTERAEMIA (8 patients)
HIP FRACTURE (8 patients)
SERRATIA BACTERAEMIA (8 patients)
DYSPEPSIA (8 patients)
ATROPHY (8 patients)
PANCREATITIS (8 patients)
HYPOKALAEMIA (8 patients)
PAROTID GLAND ENLARGEMENT (8 patients)
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (8 patients)
PRURITUS GENERALISED (8 patients)
HALLUCINATION, VISUAL (8 patients)
BONE OPERATION (8 patients)
DEBRIDEMENT (8 patients)
TRICUSPID VALVE INCOMPETENCE (8 patients)
LOCAL SWELLING (8 patients)
DIABETIC NEUROPATHY (8 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (8 patients)
CENTRAL VENOUS CATHETERISATION (8 patients)
CHILLS (8 patients)
HYPOGLYCAEMIC SEIZURE (8 patients)
SUICIDAL IDEATION (8 patients)
SOMNOLENCE (8 patients)
EPILEPSY (8 patients)
MOBILITY DECREASED (7 patients)
AGGRESSION (7 patients)
AGITATION (7 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (7 patients)
GASTRIC ULCER (7 patients)
BALANCE DISORDER (7 patients)
EMOTIONAL DISORDER (7 patients)
CEREBRAL ATROPHY (7 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (7 patients)
PNEUMONIA KLEBSIELLA (7 patients)
HYPOVOLAEMIA (7 patients)
HYPOPHAGIA (7 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for GLUCAGON


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about THERAPY NON-RESPONDER and GLUCAGON, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking GLUCAGON, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in GLUCAGON. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for GLUCAGON experts. If you are a healthcare provider experienced in prescribing GLUCAGON, please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use